AI assistant
Sending…
Mawson Infrastructure Group Inc. — Director's Dealing 2019
Apr 24, 2019
35202_dirs_2019-04-23_f2b0c309-0f95-4710-a187-5dc79eb11692.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2019-04-21
Reporting Person: Ridge Valley Corp (10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-04-21 | Convertible Loans | $1.1112 | S | 265531 | Disposed | 2019-05-31 | Common Stock (265531) | Direct |
| 2019-04-21 | Investment Rights | $1.332 | S | 94382 | Disposed | 2019-11-30 | Common Stock (94382) | Direct |
Footnotes
F1: Issuable upon the conversion of the convertible loans under the January 19, 2017 Loan Agreement (the "Loan Agreement") by and among the Issuer and Ridge Valley Corporation, among others. The Convertible Loans may be converted at any time.
F2: The purchaser waived a debt owed to him by Ridge Valley Corporation as consideration for these derivative securities.
More from Mawson Infrastructure Group Inc.
Capital/Financing Update
2026
Jun 3
Interim / Quarterly Report
2026
May 14
Board/Management Information
2026
Apr 8
Board/Management Information
2026
Apr 6
Major Shareholding Notification
2026
Mar 18
Major Shareholding Notification
2026
Feb 10
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Feb 6
Proxy Solicitation & Information Statement
2026
Feb 4
Regulatory Filings
2026
Feb 2